RENAISSANCE TECHNOLOGIES LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1037389
NEW YORK, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$25,302,900
+$17,905,956 QoQ
Shares Held
2,530,290
+225.7% QoQ
Ownership
0.990%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#24
of 316 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. BCRX ranks #11 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in BCRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,302,900 | 2,530,290 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,396,944 | 776,990 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,604,803 | 2,128,821 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,246,653 | 2,140,534 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $22,639,536 | 2,526,734 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,539,135 | 605,218 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,098,557 | 545,021 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,477,008 | 589,080 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,933,912 | 960,180 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,079,130 | 1,590,380 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,512,330 | 1,754,980 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,429,062 | 201,845 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $7,123,788 | 565,380 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,338,158 | 126,480 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,089,064 | 251,480 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $5,865,546 | 408,180 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $16,323,508 | 1,032,480 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $686,169 | 67,470 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $9,538,831 | 1,280,380 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||